Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group

A. Berardelli, A. Formica, B. Mercuri, G. Abbruzzese, A. Agnoli, R. Agostino, T. Caraceni, F. Carella, G. De Fazio, D. De Grandis, R. Eleopra, P. Girlanda, V. Lepore, C. Messina, S. Milone, A. Priori, F. Stocchi, V. Tugnoli, M. Manfredi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

In six Centers belonging to the Italian Movement Disorder Study Group, the efficacy of botulinum toxin treatment was evaluated in an open collaborative study in 251 patients with focal dystonia and hemifacial spasm. The percentage of functional improvement ranged from 66% to 81% in patients with blepharospasm, from 40% to 51% in patients with spasmodic torticollis and from 73% to 81% in those with hemifacial spasm. Good results were also obtained in patients with oromandibular dystonia, laryngeal dystonia and writer's cramp. Side effects were mild and transient. Local botulinum toxin injection is the first choice symptomatic treatment in focal dystonia and hemifacial spasm.

Original languageEnglish
Pages (from-to)361-367
Number of pages7
JournalItalian Journal of Neurological Sciences
Volume14
Issue number5
DOIs
Publication statusPublished - Jun 1993

Fingerprint

Hemifacial Spasm
Dystonic Disorders
Botulinum Toxins
Movement Disorders
Multicenter Studies
Dystonia
Blepharospasm
Torticollis
Therapeutics
Injections

Keywords

  • Botulinum toxin
  • dystonia
  • hemifacial spasm

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. / Berardelli, A.; Formica, A.; Mercuri, B.; Abbruzzese, G.; Agnoli, A.; Agostino, R.; Caraceni, T.; Carella, F.; De Fazio, G.; De Grandis, D.; Eleopra, R.; Girlanda, P.; Lepore, V.; Messina, C.; Milone, S.; Priori, A.; Stocchi, F.; Tugnoli, V.; Manfredi, M.

In: Italian Journal of Neurological Sciences, Vol. 14, No. 5, 06.1993, p. 361-367.

Research output: Contribution to journalArticle

Berardelli, A, Formica, A, Mercuri, B, Abbruzzese, G, Agnoli, A, Agostino, R, Caraceni, T, Carella, F, De Fazio, G, De Grandis, D, Eleopra, R, Girlanda, P, Lepore, V, Messina, C, Milone, S, Priori, A, Stocchi, F, Tugnoli, V & Manfredi, M 1993, 'Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group', Italian Journal of Neurological Sciences, vol. 14, no. 5, pp. 361-367. https://doi.org/10.1007/BF02340723
Berardelli, A. ; Formica, A. ; Mercuri, B. ; Abbruzzese, G. ; Agnoli, A. ; Agostino, R. ; Caraceni, T. ; Carella, F. ; De Fazio, G. ; De Grandis, D. ; Eleopra, R. ; Girlanda, P. ; Lepore, V. ; Messina, C. ; Milone, S. ; Priori, A. ; Stocchi, F. ; Tugnoli, V. ; Manfredi, M. / Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. In: Italian Journal of Neurological Sciences. 1993 ; Vol. 14, No. 5. pp. 361-367.
@article{c3034d48f9684438bfaad2b38d8fae20,
title = "Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group",
abstract = "In six Centers belonging to the Italian Movement Disorder Study Group, the efficacy of botulinum toxin treatment was evaluated in an open collaborative study in 251 patients with focal dystonia and hemifacial spasm. The percentage of functional improvement ranged from 66{\%} to 81{\%} in patients with blepharospasm, from 40{\%} to 51{\%} in patients with spasmodic torticollis and from 73{\%} to 81{\%} in those with hemifacial spasm. Good results were also obtained in patients with oromandibular dystonia, laryngeal dystonia and writer's cramp. Side effects were mild and transient. Local botulinum toxin injection is the first choice symptomatic treatment in focal dystonia and hemifacial spasm.",
keywords = "Botulinum toxin, dystonia, hemifacial spasm",
author = "A. Berardelli and A. Formica and B. Mercuri and G. Abbruzzese and A. Agnoli and R. Agostino and T. Caraceni and F. Carella and {De Fazio}, G. and {De Grandis}, D. and R. Eleopra and P. Girlanda and V. Lepore and C. Messina and S. Milone and A. Priori and F. Stocchi and V. Tugnoli and M. Manfredi",
year = "1993",
month = "6",
doi = "10.1007/BF02340723",
language = "English",
volume = "14",
pages = "361--367",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group

AU - Berardelli, A.

AU - Formica, A.

AU - Mercuri, B.

AU - Abbruzzese, G.

AU - Agnoli, A.

AU - Agostino, R.

AU - Caraceni, T.

AU - Carella, F.

AU - De Fazio, G.

AU - De Grandis, D.

AU - Eleopra, R.

AU - Girlanda, P.

AU - Lepore, V.

AU - Messina, C.

AU - Milone, S.

AU - Priori, A.

AU - Stocchi, F.

AU - Tugnoli, V.

AU - Manfredi, M.

PY - 1993/6

Y1 - 1993/6

N2 - In six Centers belonging to the Italian Movement Disorder Study Group, the efficacy of botulinum toxin treatment was evaluated in an open collaborative study in 251 patients with focal dystonia and hemifacial spasm. The percentage of functional improvement ranged from 66% to 81% in patients with blepharospasm, from 40% to 51% in patients with spasmodic torticollis and from 73% to 81% in those with hemifacial spasm. Good results were also obtained in patients with oromandibular dystonia, laryngeal dystonia and writer's cramp. Side effects were mild and transient. Local botulinum toxin injection is the first choice symptomatic treatment in focal dystonia and hemifacial spasm.

AB - In six Centers belonging to the Italian Movement Disorder Study Group, the efficacy of botulinum toxin treatment was evaluated in an open collaborative study in 251 patients with focal dystonia and hemifacial spasm. The percentage of functional improvement ranged from 66% to 81% in patients with blepharospasm, from 40% to 51% in patients with spasmodic torticollis and from 73% to 81% in those with hemifacial spasm. Good results were also obtained in patients with oromandibular dystonia, laryngeal dystonia and writer's cramp. Side effects were mild and transient. Local botulinum toxin injection is the first choice symptomatic treatment in focal dystonia and hemifacial spasm.

KW - Botulinum toxin

KW - dystonia

KW - hemifacial spasm

UR - http://www.scopus.com/inward/record.url?scp=0027209403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027209403&partnerID=8YFLogxK

U2 - 10.1007/BF02340723

DO - 10.1007/BF02340723

M3 - Article

C2 - 8354632

AN - SCOPUS:0027209403

VL - 14

SP - 361

EP - 367

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 5

ER -